{"filing":{"accession_number":"0001731122-26-001179","cik":"0001314052","ticker":"AVXL","company_name":"ANAVEX LIFE SCIENCES CORP.","form":"8-K","filing_date":"2026-09-02","report_date":"2026-09-02","primary_document":"e7909_8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/e7909_8-k.htm"},"events":[{"id":31389,"run_id":28794,"accession_number":"0001731122-26-001179","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The disclosure centers on Anavex's regaining compliance with Nasdaq Listing Rule 5250(c)(1) after receiving a delinquency notification for failure to timely file required periodic reports (Form 10-Q). While the filing announces resolution of the compliance issue, the underlying event—the company's prior non-compliance and delisting risk—is material to investors. The company explicitly references the delinquency notification and its plan to regain compliance, confirming this was a delisting-risk situation that has now been remedied.","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-02","form":"8-K","submitted_at":null,"items":[{"id":34247,"accession_number":"0001731122-26-001179","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Anavex's regaining compliance with Nasdaq Listing Rule 5250(c)(1) after receiving a delinquency notification for failure to timely file required periodic reports (Form 10-Q). While the filing announces resolution of the compliance issue, the underlying event—the company's prior non-compliance and delisting risk—is material to investors. The company explicitly references the delinquency notification and its plan to regain compliance, confirming this was a delisting-risk situation that has now been remedied.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T21:07:54.191579+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":34247,"accession_number":"0001731122-26-001179","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on Anavex's regaining compliance with Nasdaq Listing Rule 5250(c)(1) after receiving a delinquency notification for failure to timely file required periodic reports (Form 10-Q). While the filing announces resolution of the compliance issue, the underlying event—the company's prior non-compliance and delisting risk—is material to investors. The company explicitly references the delinquency notification and its plan to regain compliance, confirming this was a delisting-risk situation that has now been remedied.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-02T21:07:54.191579+00:00","company_name":"ANAVEX LIFE SCIENCES CORP.","ticker":"AVXL","filing_date":"2026-09-02"}]}